The Adipocyte-Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy.
Sofía SanhuezaLayla SimónMariana CifuentesAndrew Frederick Geoffery QuestPublished in: Antioxidants (Basel, Switzerland) (2023)
Obesity has emerged as a major public health concern with a staggering 39% worldwide prevalence as of 2021. Given the magnitude of the problem and considering its association with chronic low-grade systemic inflammation, it does not come as a surprise that obesity is now considered one of the major risk factors for the development of several chronic diseases, such as diabetes, cardiovascular problems, and cancer. Adipose tissue dysfunction in obesity has taken center stage in understanding how changes in its components, particularly adipocytes and macrophages, participate in such processes. In this review, we will initially focus on how changes in adipose tissue upon excess fat accumulation generate endocrine signals that promote cancer development. Moreover, the tumor microenvironment or stroma, which is also critical in cancer development, contains macrophages and adipocytes, which, in reciprocal paracrine communication with cancer cells, generate relevant signals. We will discuss how paracrine signaling in the tumor microenvironment between cancer cells, macrophages, and adipocytes favors cancer development and progression. Finally, as reactive oxygen species participate in many of these signaling pathways, we will summarize the information available on how antioxidants can limit the effects of endocrine and paracrine signaling due to dysfunctional adipose tissue components in obesity.
Keyphrases
- adipose tissue
- insulin resistance
- papillary thyroid
- type diabetes
- metabolic syndrome
- squamous cell
- public health
- high fat diet induced
- low grade
- high fat diet
- weight loss
- cardiovascular disease
- reactive oxygen species
- mental health
- lymph node metastasis
- squamous cell carcinoma
- mesenchymal stem cells
- fatty acid
- climate change
- pi k akt
- health information
- smoking cessation
- replacement therapy